Production of monoclonal antibodies and antibody derivates can be carried out using a variety of mammalian cell lines, ranging from the widely-used CHO-cells to our proprietary human cells, ensuring a glyco-optimisation.
Systems used are either stainless steel fermenters, ranging from ten to 200 litres, or single use bioreactors, ranging from 20 to 1,000 litres. Upon our customers’ request, these fermenters can be run in fed-batch, or perfusion mode.
Click here for more information.